All Stories

AbbVie taps oncology research institute for aid running diverse cancer trials

AbbVie is looking south to boost its community-based clinical trials. The Chicago-area pharma giant is partnering with Nashville-based Sarah Cannon Research Institute to run diverse trials for AbbVie’s novel cancer candidates.

May 28, 2025 - 17:30
 0
AbbVie taps oncology research institute for aid running diverse cancer trials
AbbVie is looking south to boost its community-based clinical trials. The Chicago-area pharma giant is partnering with Nashville-based Sarah Cannon Research Institute to run diverse trials for AbbVie’s novel cancer candidates.
Read More

Tags:

Previous Article

Scynexis says GSK on hook for $10M payment after phase 3 Brexafemme trial starts...

Next Article

Cancer drugmaker iTeos to shut down

Related Posts

ASCO: Cullinan, Taiho unveil lung cancer data behind FDA application plans

ASCO: Cullinan, Taiho unveil lung cancer data behind FD...

May 22, 2025  0

Kinase inhibitor biotech Enliven calls time on ph. 1 HER2 solid tumor program

Kinase inhibitor biotech Enliven calls time on ph. 1 HE...

May 15, 2025  0

GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs

GSK axes $625M TIGIT drug as midphase data disappoint, ...

May 13, 2025  0